Build what differentiates you. Buy what doesn't. Your product is your business. Your testing infrastructure is not.
Many pathology groups have a common misunderstanding when expanding into molecular testing: underestimating the operational burden of later ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results